{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:56:33Z","timestamp":1792292193380,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.ahj.2005.07.030","type":"journal-article","created":{"date-parts":[[2006,6,16]],"date-time":"2006-06-16T07:57:21Z","timestamp":1150444641000},"page":"1147-1155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["Cardiovascular disease in HIV infection"],"prefix":"10.1016","volume":"151","author":[{"given":"Isabella","family":"Sudano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas E.","family":"Spieker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Noll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"L\u00fcscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2005.07.030_bib1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/archinte.165.4.416","article-title":"The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy","volume":"165","author":"d'Arminio Monforte","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.07.030_bib2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJM199909303411406","article-title":"The AIDS epidemic\u2014considerations for the 21st century","volume":"341","author":"Fauci","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.07.030_bib3","series-title":"AIDS epidemic update: December 2004","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS) WHO","year":"2004"},{"issue":"Suppl 1","key":"10.1016\/j.ahj.2005.07.030_bib4","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1086\/425284","article-title":"This place is killing me: a comparison of counties where the incidence rates of AIDS increased the most and the least","volume":"191","author":"Peterman","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ahj.2005.07.030_bib5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/jinf.2000.0672","article-title":"Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement","volume":"40","author":"Pugliese","year":"2000","journal-title":"J Infect"},{"key":"10.1016\/j.ahj.2005.07.030_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000177367","article-title":"Clinical and echocardiographic findings in HIV patients with pericardial effusion","volume":"88","author":"Moreno","year":"1997","journal-title":"Cardiology"},{"key":"10.1016\/j.ahj.2005.07.030_bib7","first-page":"736","article-title":"Pericardial involvement in an HIV-infected patient","volume":"129","author":"Lepori","year":"1999","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.ahj.2005.07.030_bib8","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1086\/322621","article-title":"Tuberculous pericarditis: optimal diagnosis and management","volume":"33","author":"Trautner","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ahj.2005.07.030_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/hrt.70.4.376","article-title":"Prevalence of toxoplasma myocarditis in patients with the acquired immunodeficiency syndrome","volume":"70","author":"Hofman","year":"1993","journal-title":"Br Heart J"},{"key":"10.1016\/j.ahj.2005.07.030_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/euhj.1998.1239","article-title":"Prevalence of heart failure and left ventricular dysfunction in the general population; the Rotterdam Study","volume":"20","author":"Mosterd","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2005.07.030_bib11","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJM200212053472320","article-title":"Cardiomyopathy with mitochondrial damage associated with nucleoside reverse-transcriptase inhibitors","volume":"347","author":"Frerichs","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.07.030_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0146-2806(99)80001-2","article-title":"Tumors of the heart and pericardium","volume":"24","author":"McAllister","year":"1999","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.ahj.2005.07.030_bib13","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1378\/chest.95.6.1359","article-title":"Pericardial effusion and tamponade due to Kaposi's sarcoma in acquired immunodeficiency syndrome","volume":"95","author":"Stotka","year":"1989","journal-title":"Chest"},{"key":"10.1016\/j.ahj.2005.07.030_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-115-5-370","article-title":"Cardiac lymphoma in a patient with AIDS","volume":"115","author":"Kelsey","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2005.07.030_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000174817","article-title":"A case of malignant lymphoma simulating acute myocardial infarction","volume":"78","author":"Nishikawa","year":"1991","journal-title":"Cardiology"},{"key":"10.1016\/j.ahj.2005.07.030_bib16","doi-asserted-by":"crossref","unstructured":"Miro JM, del Rio A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin 2003;21:167-84, v-vi.","DOI":"10.1016\/S0733-8651(03)00025-0"},{"key":"10.1016\/j.ahj.2005.07.030_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/clinids\/22.1.40","article-title":"Infective endocarditis in injection drug users: importance of human immunodeficiency virus serostatus and degree of immunosuppression","volume":"22","author":"Pulvirenti","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ahj.2005.07.030_bib18","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0248-8663(01)00491-X","article-title":"Primary pulmonary hypertension in human immunodeficiency virus infection. Study of 9 cases and review of the literature","volume":"22","author":"Le Houssine","year":"2001","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.ahj.2005.07.030_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0025-6196(11)63616-1","article-title":"Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases","volume":"73","author":"Mesa","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ahj.2005.07.030_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1749-6632.2001.tb03904.x","article-title":"Pathogenesis of HIV-related pulmonary hypertension","volume":"946","author":"Pellicelli","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ahj.2005.07.030_bib21","doi-asserted-by":"crossref","first-page":"231S","DOI":"10.1378\/chest.114.3_Supplement.231S","article-title":"Genetics and immunogenetic aspects of primary pulmonary hypertension","volume":"114","author":"Barst","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.ahj.2005.07.030_bib22","first-page":"97","article-title":"Pulmonary artery hypertension in HIV seropositive drug addicts. Apropos of 10 cases","volume":"15","author":"Petureau","year":"1998","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.ahj.2005.07.030_bib23","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2165\/00003495-200161130-00005","article-title":"Current management of primary pulmonary hypertension","volume":"61","author":"Klings","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.ahj.2005.07.030_bib24","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1164\/ajrccm.162.5.2004042","article-title":"Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension","volume":"162","author":"Aguilar","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ahj.2005.07.030_bib25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4414\/smw.2001.09842","article-title":"Regression of HIV-associated pulmonary arterial hypertension and long-term survival during antiretroviral therapy","volume":"131","author":"Speich","year":"2001","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.ahj.2005.07.030_bib26","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/000331979804901206","article-title":"Role of human immunodeficiency virus in primary pulmonary hypertension\u2014case reports","volume":"49","author":"Pellicelli","year":"1998","journal-title":"Angiology"},{"key":"10.1016\/j.ahj.2005.07.030_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/ejvs.2000.1169","article-title":"Clinical profile of HIV-related aneurysms","volume":"20","author":"Nair","year":"2000","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ahj.2005.07.030_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jcp.54.4.275","article-title":"Vasculitides associated with HIV infection","volume":"54","author":"Chetty","year":"2001","journal-title":"J Clin Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.ahj.2005.07.030_bib29","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1097\/00002030-200304001-00010","article-title":"Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era","volume":"17","author":"Vittecoq","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.ahj.2005.07.030_bib30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","article-title":"Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection","volume":"348","author":"Bozzette","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.07.030_bib31","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1053\/euhj.2000.2264","article-title":"Clinical outcome after coronary events in patients treated with HIV-protease inhibitors","volume":"21","author":"Monsuez","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2005.07.030_bib32","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(02)11672-2","article-title":"Protease inhibitors and cardiovascular outcomes in patients with HIV-1","volume":"360","author":"Holmberg","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.07.030_bib33","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients\u2014association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-Moller","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.ahj.2005.07.030_bib34","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.07.030_bib35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.CIR.104.3.257","article-title":"Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction","volume":"104","author":"Stein","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.07.030_bib36","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1172\/JCI200215626","article-title":"Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1\u2013infected patients with lipodystrophy","volume":"110","author":"Behrens","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ahj.2005.07.030_bib37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1172\/JCI200316261","article-title":"HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages","volume":"111","author":"Dressman","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ahj.2005.07.030_bib38","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00126334-200304150-00004","article-title":"Brief report: carotid intima-media thickness in heavily pretreated HIV-infected patients","volume":"32","author":"Chironi","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ahj.2005.07.030_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00126334-200209010-00007","article-title":"Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: the Swiss HIV Cohort Study","volume":"31","author":"Bernasconi","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ahj.2005.07.030_bib40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1468-1293.2001.00073.x","article-title":"The prevalence of lipodystrophy in an ambulant HIV-infected population: it all depends on the definition","volume":"2","author":"Carter","year":"2001","journal-title":"HIV Med"},{"key":"10.1016\/j.ahj.2005.07.030_bib41","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor\u2013associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.07.030_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.apnr.2004.09.012","article-title":"Lipodystrophy and quality of life in HIV: symptom management issues","volume":"18","author":"Nicholas","year":"2005","journal-title":"Appl Nurs Res"},{"key":"10.1016\/j.ahj.2005.07.030_bib43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.07.030_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(03)00246-6","article-title":"HIV-related lipodystrophy and related factors","volume":"174","author":"Tershakovec","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2005.07.030_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0002-9149(03)00631-3","article-title":"Frequency of and outcome of acute coronary syndromes in patients with human immunodeficiency virus infection","volume":"92","author":"Ambrose","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.07.030_bib46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.CIR.0000114520.38748.AA","article-title":"Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.07.030_bib47","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.amjcard.2004.11.004","article-title":"Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy","volume":"95","author":"Grover","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.07.030_bib48","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/378131","volume":"37","author":"Dube","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ahj.2005.07.030_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jac\/dkh013","article-title":"Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients","volume":"53","author":"Calza","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ahj.2005.07.030_bib50","first-page":"277","article-title":"Prescribing of contraindicated protease inhibitor and statin combinations among HIV-infected persons","volume":"38","author":"Hulgan","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ahj.2005.07.030_bib51","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/00002030-200211080-00012","article-title":"A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor\u2013associated hypertriglyceridaemia","volume":"16","author":"Miller","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.ahj.2005.07.030_bib52","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/00002030-200109280-00010","article-title":"HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study","volume":"15","author":"Carr","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.ahj.2005.07.030_bib53","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1056\/NEJMoa021589","article-title":"Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection","volume":"349","author":"Martinez","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.07.030_bib54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.288.2.207","article-title":"Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial","volume":"288","author":"Carr","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.07.030_bib55","unstructured":"Cofrancesco Jr J, Brown T, Martins CR. Management options for facial lipoatrophy. AIDS Read 2004;14:639-40, 645-50."},{"key":"10.1016\/j.ahj.2005.07.030_bib56","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S1010-7940(03)00162-3","article-title":"Long-term results after cardiac surgery in patients infected with the human immunodeficiency virus type-1 (HIV-1)","volume":"23","author":"Mestres","year":"2003","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ahj.2005.07.030_bib57","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0003-4975(03)00514-9","article-title":"Cardiac valve replacement in human immunodeficiency virus\u2013infected patients","volume":"76","author":"Chong","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2005.07.030_bib58","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1056\/NEJMsb020632","article-title":"Solid organ transplantation in HIV-infected patients","volume":"347","author":"Halpern","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.07.030_bib59","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1056\/NEJMoa022935","article-title":"Successful cardiac transplantation in an HIV-1\u2013infected patient with advanced disease","volume":"348","author":"Calabrese","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.07.030_bib60","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1056\/NEJMp030074","article-title":"Responding to organ failure in HIV-infected patients","volume":"348","author":"Roland","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.07.030_bib61","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1182\/blood.V98.13.3857","article-title":"Autologous stem cell transplantation for HIV-associated lymphoma","volume":"98","author":"Krishnan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ahj.2005.07.030_bib62","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF01541321","article-title":"Inhibitory effect of the immunosuppressant FK506 on apoptotic cell death induced by HIV-1 gp120","volume":"15","author":"Sekigawa","year":"1995","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ahj.2005.07.030_bib63","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0041-1345(02)03011-7","article-title":"Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus\u2013positive liver and kidney transplantation patients","volume":"34","author":"Jain","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ahj.2005.07.030_bib64","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0021-9150(01)00736-5","article-title":"Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors","volume":"162","author":"Seminari","year":"2002","journal-title":"Atherosclerosis"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305007581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305007581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:27:23Z","timestamp":1757568443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870305007581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0002870305007581"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2005.07.030","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular disease in HIV infection","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2005.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}